PETS opened at $16.23 on Wednesday. The firm’s fifty day moving average price is $16.42. The stock has a market cap of $329.24 million, a price-to-earnings ratio of 8.85 and a beta of 0.52. Petmed Express has a one year low of $15.00 and a one year high of $41.45.
Petmed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, May 6th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.14). Petmed Express had a return on equity of 28.96% and a net margin of 13.32%. The company had revenue of $64.57 million for the quarter, compared to the consensus estimate of $69.06 million. During the same period in the prior year, the firm posted $0.50 earnings per share. The business’s revenue was down 4.1% on a year-over-year basis.
About Petmed Express
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Featured Article: What are catch-up contributions?
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.